A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

NCT01706159 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Trial screening data did not support the medical hypothesis

Conditions

Inflammation
Ulcerative Colitis

Interventions

DRUG: catridecacog
DRUG: placebo

Sponsor

Novo Nordisk A/S